Canaccord Genuity Group's Rating of Lineage Cell Therapeutics on 4/28/2026 On April 28, 2026, Canaccord Genuity Group updated its outlook on Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page. Upgrade to MarketBeat All AccessThis premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.Upgrade Now See Benefits Already have an account? Log in here. More Ratings on Lineage Cell TherapeuticsDateBrokerageAction7/14/2026 HC WainwrightSubscribe to MarketBeat All Access to unlock brokerage rankingsReiterated Rating5/4/2026 D. Boral CapitalSubscribe to MarketBeat All Access to unlock brokerage rankingsReiterated Rating3/25/2026 B. Riley FinancialSubscribe to MarketBeat All Access to unlock brokerage rankingsBoost Price Target3/24/2026 HC WainwrightSubscribe to MarketBeat All Access to unlock brokerage rankingsReiterated Rating3/6/2026 HC WainwrightSubscribe to MarketBeat All Access to unlock brokerage rankingsReiterated Rating3/6/2026 D. Boral CapitalSubscribe to MarketBeat All Access to unlock brokerage rankingsBoost Price TargetMore Lineage Cell Therapeutics, Inc. Ratings More Ratings from Canaccord Genuity Group Inc.DateCompanyAction11/12/2026KOPNKopinBoost Price Target11/12/2026MASS908 DevicesBoost Price Target11/12/2026MRCYMercury SystemsBoost Price Target11/12/2026HIVEHIVE Digital TechnologiesLower Price Target11/11/2026ACHRArcher AviationLower Price Target11/11/2026AMRCAmerescoLower Price TargetMore Ratings From Canaccord Genuity Group Inc. Return to Ratings Search Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche BankBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
